Income statement
USD
Annual
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 9M | 11M | 13M |
| Gross Profit | 4M | 5M | 6M |
| Operating Income | 2M | 3M | 3M |
| EBITDA | 3M | 4M | 4M |
| Net Income | 2M | 4M | 4M |
| EPS (Diluted) | — | — | — |
Consumer Defensive
Live Price
Offline$8.31
+1.96% today
Window Change
+25.20%
Window
Jan 6, 2026 → Jun 26, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 119 bars · Jan 6, 2026 → Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Buda Juice, Inc. (BUDA) is a Consumer Defensive stock with a market cap of $120.00M. The stock last traded around $8.31 and up 25.2% across the available one-year price window (Jan 6, 2026 → Jun 26, 2026). Baseline metrics include revenue growth of +11.8%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue +11.8%, EPS 0.0%, free cash flow 0.0% with operating margin 27.4% and ROIC 0.0%. Stock Foundry combines BUDA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BUDA
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BUDA Max Drawdown
-33.08%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BUDA and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$12.6M
+11.8% YoY
FY Net Income
$3.5M
-1.1% YoY
Free Cash Flow
$2.9M
-11.7% YoY
Revenue Growth
+11.8%
EPS Growth
+0.0%
Gross Margin
44.6%
Net Margin
28.0%
Income statement
USD
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 9M | 11M | 13M |
| Gross Profit | 4M | 5M | 6M |
| Operating Income | 2M | 3M | 3M |
| EBITDA | 3M | 4M | 4M |
| Net Income | 2M | 4M | 4M |
| EPS (Diluted) | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| Cash & Equivalents | 1M | 2M | 2M |
| Total Assets | 3M | 4M | 5M |
| Total Liabilities | 3M | 575K | 1M |
| Shareholder Equity | — | — | — |
| Total Debt | 181K | 68K | 782K |
| Net Debt | — | — | — |
Cash flow positioning
2026 Full Year
Operating Cash Flow
4M
-6.6% YoY
Capital Expenditures
—
Free Cash Flow
3M
-11.7% YoY
Key ratios
Gross Margin
44.6%
Operating Margin
27.4%
Net Margin
28.0%
ROE
0.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.